The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease
Abstract
Neurofibrillary degeneration in the nucleus basalis and a loss of its cortical cholinergic projections are prominent components of the neuropathology in Alzheimer's disease (AD). The AD brain is also associated with a degeneration of the noradrenergic projections arising from the nucleus locus coeruleus (LC), but the time course of this lesion is poorly understood. To determine whether the LC displays neurofibrillary abnormalities early in the course of events leading to AD, we examined tissue specimens from seven cognitively normal controls and five subjects at the stages of mild cognitively impairment (MCI) or early AD. Tyrosine hydroxylase immunochemistry was used as a marker of LC neurons while AT8 immunolabeling visualized abnormal tau associated with neurofibrillary tangles and their precursors. Thioflavine-S was used as a marker for fully developed tangles. We found that AT8-positive labeling and thioflavine-S positive tangles were present in both groups of specimens. However, the percentage of neurons containing each of these markers was significantly higher in the cognitively impaired group. The MMSE scores displayed a negative correlation with both markers of cytopathology. These results indicate that cytopathology in the LC is an early event in the age-MCI-AD continuum and that it may be listed among the numerous factors that mediate the emergence of the cognitive changes leading to dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Subsequent studies identified the locus coeruleus as the first site of pathology in AD subjects, with NFTs preceding cortical tau or Aβ deposits [41–43].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [42]
In the citing paper
“As AD progresses, the NFTs become numerous in locus coeruleus which may suggest the same pathogenetic process is becoming more severe (301).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [301]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Population-Based Norms for the Mini-Mental State Examination by Age and Educational Level
Crum, R. M. (1993) · JAMA · doi:10.1001/jama.1993.03500180078038 · Cited by 2,958
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
A Compendium of Neuropsychological Tests
Selnes, O. A. (1991) · Neurology · doi:10.1212/wnl.41.11.1856-a · Cited by 2,278
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,147
Research works printed but not linked: 1
- Knight, 1970, Histochemical demonstration of the catecholamines and acetylcholine esterase in the same cell bodies in the locus ceruleus (rat hind brain), Proc R Microsc Soc, 6, 26
Cited by
Sorted by citations
Items 201–300 of 392
Sakakibara, Y., Hirota, Y., Ibaraki, K., Takei, K., Chikamatsu, S., Tsubokawa, Y., Saito, T., Saido, T. C., Sekiya, M., & Iijima, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210385 · Cited by 26
Clement, A., Wiborg, O., & Asuni, A. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00056 · Cited by 28
Evans, A. K., Park, H. H., Saw, N. L., Singhal, K., Ogawa, G., Leib, R. D., & Shamloo, M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.012 · Cited by 25
Associations between MRI-assessed locus coeruleus integrity and cortical gray matter microstructure
Elman, J. A., Puckett, O. K., Hagler, D. J., Pearce, R. C., Fennema‐Notestine, C., Hatton, S. N., Lyons, M. J., McEvoy, L. K., Panizzon, M. S., Reas, E. T., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab475 · Cited by 25
Yi, Y., Lüsebrink, F., Ludwig, M., Maaß, A., Ziegler, G., Yakupov, R., Kreissl, M. C., Betts, M. J., Speck, O., Düzel, E., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.04.007 · Cited by 29
Becker, B., Androsch, L., Jahn, R. T., Alich, T. C., Striepens, N., Markett, S. A., Maier, W., & Hurlemann, R. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00197 · Cited by 25
Exposure to acrylamide decreases noradrenergic axons in rat brain
Zhang, L., Hara, S., Ichinose, H., Nagashima, D., Morita, K., Sakurai, T., Ichihara, S., & Ichihara, G. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.03.001 · Cited by 25
Selective neuronal vulnerability in Alzheimer’s disease
Wang, Z.-T., Zhang, C. M., Wang, Y., Dong, Q., Tan, L., & Yu, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101114 · Cited by 24
Gallo, A., Pillet, L., & Verpillot, R. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111452 · Cited by 25
Daulatzai, M. A. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9643-3 · Cited by 27
Wang, Z., Cao, X., LaBella, A., Zeng, X., Biegon, A. R., Franceschi, D., Petersen, E. W., Clayton, N., Ulaner, G. A., Zhao, W., et al. (2022) · Medical Physics · doi:10.1002/mp.15653 · Cited by 23
Ageing-Related Neurodegeneration and Cognitive Decline
Alafuzoff, I. I., & Libard, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074065 · Cited by 27
Chen, G., Wang, M., Zhang, Z., Hong, D. K., Ahn, E. H., Liu, X., Kang, S. S., & Ye, K. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.015 · Cited by 21
Iatrou, A., Kenis, G., Rutten, B. P. F., Lunnon, K., & van den Hove, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2361-4 · Cited by 22
Emerging Functions of Neuromodulation during Sleep
Sulaman, B. A., Zhang, Y., Matosevich, N., Kjærby, C., Foustoukos, G., Andersen, M., & Eban-Rothschild, A. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1277-24.2024 · Cited by 24
de Leo, G., Gulino, R., Coradazzi, M., & Leanza, G. (2022) · Brain Communications · doi:10.1093/braincomms/fcac338 · Cited by 20
Pillet, L., Taccola, C., Cotoni, J., Thiriez, H., André, K., & Verpillot, R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01102-y · Cited by 20
Using Drosophila amyloid toxicity models to study Alzheimer's disease
Tsintzas, E., & Niccoli, T. (2024) · Annals of Human Genetics · doi:10.1111/ahg.12554 · Cited by 20
Hary, A. T., Chadha, S., Mercaldo, N. D., Smith, E. N., van der Kouwe, A. J. W., Fischl, B. R., Mount, C., Kozanno, L. N., Frosch, M. P., & Augustinack, J. C. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01957-6 · Cited by 24
Oikawa, N., Ogino, K., Masumoto, T., Yamaguchi, H., & Yanagisawa, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.005 · Cited by 19
Luckey, A. M., Robertson, I. H., LAWLOR, B. A., Mohan, A., & Vanneste, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210404 · Cited by 24
Dyer-Reaves, K., Goodman, A. M., Nelson, A. R., & McMahon, L. L. (2019) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2019.00027 · Cited by 17
Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer’s Disease
Patthy, Á., Murai, J., Hanics, J., Pintér, A., Zahola, P., Hökfelt, T. G. M., Harkany, T., & Alpár, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081555 · Cited by 17
The β‐adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease
Li, S. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15782 · Cited by 18
Vicente, M. C., Paneghini, J. D. L., Stabile, A. M., Amorim, M. R., Silva, C. E. A., Patrone, L. G. A., Cunha, T. M., Bícego, K. C., Almeida, M. C., Carrettiero, D. C., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230151 · Cited by 21
Monoamine Oxidase-A Physically Interacts with Presenilin-1(M146V) in the Mouse Cortex
Wei, Z.-L., Gabriel, G. G., Rui, L., Cao, X., Pennington, P. R., Chlan‐Fourney, J., Nazarali, A., Baker, G., & Mousseau, D. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111241 · Cited by 18
Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model
Martin, S. B., Dowling, A. L. S., & Head, E. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376217 · Cited by 19
Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease
Buckley, R. F. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01026-5 · Cited by 18
Pirker-Kees, A., Dal-Bianco, P., & Schmidt, R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181102 · Cited by 17
Aguilar, L. F., Hall, H., Orciani, C., Foret, M. K., Kovecses, O., Ducatenzeiler, A., & Cuello, A. C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12835 · Cited by 17
Szabo, A. B., Cattaud, V., Bezzina, C., Dard, R. F., Sayegh, F. J. P., Gauzin, S., Lejards, C., Valton, L., Rampon, C., Verret, L., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.11.017 · Cited by 18
Beardmore, R., Durkin, M., Zayee‐Mellick, F., Lau, L. C., Nicoll, J. A. R., Holmes, C., & Boche, D. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12965 · Cited by 17
Clapcote, S. J. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_5 · Cited by 18
Delbono, O., Wang, Z., & Messi, M. L. (2022) · Acta Physiologica · doi:10.1111/apha.13887 · Cited by 17
Articulatory Agility in Cognitive Decline
Östberg, P., Bogdanović, N., & Wahlund, L. (2009) · Folia Phoniatrica et Logopaedica · doi:10.1159/000235649 · Cited by 17
Weber, L. M., Divecha, H. R., Tran, M. N., Kwon, S., Spangler, A., Montgomery, K. D., Tippani, M., Bharadwaj, R. A., Kleinman, J. E., Page, S. C., et al. (2023) · eLife · doi:10.7554/elife.84628 · Cited by 33
Possible role of locus coeruleus neuronal loss in age-related memory and attention deficits
Gargano, A., Olabiyi, B. F., Palmisano, M., Zimmer, A., & Bilkei‐Gorzó, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1264253 · Cited by 17
Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects
Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21
Hippocampal Network Alterations in Alzheimer's Disease and Down Syndrome: From Structure to Therapy
Sanchez, M. M., Moghadam, S., Naik, P. K., Martin, K. J., & Salehi, A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0050 · Cited by 17
In vivo Brainstem Imaging in Alzheimer’s Disease: Potential for Biomarker Development
Braun, D. J., & Eldik, L. J. V. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00266 · Cited by 16
Aghajanov, M. I., Chavushyan, V. A., Matinyan, S., Danielyan, M., & Yenkoyan, K. B. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104531 · Cited by 16
Liu, Y. M., Lee, M. K., James, M. M., Price, D. L., Borchelt, D., Troncoso, J. C., & Oh, E. S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101602 · Cited by 16
Attention enhancing effects of methylphenidate are age-dependent
Bhattacharya, S. E., Shumsky, J. S., & Waterhouse, B. D. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.11.006 · Cited by 17
Late reaction times identify MCI
Fernaeus, S., Östberg, P., & Wahlund, L. (2013) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12053 · Cited by 16
Li, Q., Yang, T., Guo, A., & Fan, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8378 · Cited by 16
He, M., Heindel, W. C., Nassar, M. R., Siefert, E. M., & Festa, E. K. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.025 · Cited by 16
Pennington, P. R., Wei, Z.-L., Rui, L., Doig, J., Graham, B., Kuski, K., Gabriel, G. G., & Mousseau, D. (2011) · Journal of neural transmission · doi:10.1007/s00702-011-0616-7 · Cited by 15
Pintus, R., Riggi, M., Cannarozzo, C., Valeri, A., de Leo, G., Romano, M., Gulino, R., & Leanza, G. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24397 · Cited by 15
Noradrenergic pathways of locus coeruleus in Parkinson’s and Alzheimer’s pathology
Singh, S. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1667799 · Cited by 17
FDG-PET assessment of the locus coeruleus in Alzheimer’s disease
Liu, K. Y., Acosta‐Cabronero, J., Hong, Y. T., Yi, Y., Hämmerer, D., & Howard, R. J. (2021) · Neuroimage Reports · doi:10.1016/j.ynirp.2020.100002 · Cited by 17
Kelly, S. C., Nelson, P. T., & Counts, S. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab017 · Cited by 15
Attentional network changes in subjective cognitive decline
Esmaeili, M., Nejati, V., Shati, M., Vatan, R. F., Chehrehnegar, N., & Foroughan, M. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-02005-8 · Cited by 15
Nguyen, T. V., Crumpacker, R. H., Calderon, K., Garcia, F. G., Zbesko, J. C., Frye, J. B., Gonzalez, S., Becktel, D. A., Yang, T., Tavera-Garcia, M. A., et al. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000711 · Cited by 15
Cognitive Impairment in Alzheimer’s and Metabolic Diseases: A Catecholaminergic Hypothesis
Guzmán-Ramos, K. R., Osorio‐Gómez, D., & Bermúdez‐Rattoni, F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.031 · Cited by 15
Chang, Y. Z., Liu, J., Xu, X., Sun, S., Zhang, J., Zhang, X., Lu, G., Xiao, S., Cao, Y., Wu, R., et al. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-07016-x · Cited by 14
Oh, Y.-C., Jeong, Y. H., Pak, M. E., & Go, Y. (2020) · Nutrients · doi:10.3390/nu12072019 · Cited by 14
Diffusion MRI tractography of the locus coeruleus‐transentorhinal cortex connections using GO‐ESP
Solders, S. K., Galinsky, V. L., Clark, A. L., Sorg, S. F., Weigand, A. J., Bondi, M. W., & Frank, L. R. (2021) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29088 · Cited by 12
Nyarko, J. N. K., Quartey, M. O., Heistad, R. M., Pennington, P. R., Poon, L. J., Knudsen, K. J., Allonby, O., Zawily, A. M. E., Freywald, A., Rauw, G., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00545 · Cited by 13
Magnusson, K. R., & Brim, B. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00158-6 · Cited by 14
Jackisch, R., Gansser, S., & Cassel, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.011 · Cited by 14
Biology enters the scene—a new perspective on bilingualism, cognition, and dementia
Bak, T. H., & Robertson, I. H. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.020 · Cited by 14
Mir, F. A., Jha, S. K., & Nehs, C. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106442 · Cited by 17
Benarroch, E. E. (2023) · Neurology · doi:10.1212/wnl.0000000000206736 · Cited by 12
Matsumoto, H., Tagai, K., Endo, H., Matsuoka, K., Takado, Y., Kokubo, N., Shimada, H., Goto, T., Goto, T. K., & Higuchi, M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230581 · Cited by 15
Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?
Nyarko, J. N. K., Quartey, M. O., Baker, G. B., & Mousseau, D. D. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743718772514 · Cited by 12
Duffy, K. B., Ray, B., Lahiri, D. K., Tilmont, E. M., Tinkler, G. P., Herbert, R. L., Greig, N. H., Ingram, D. K., Ottinger, M. A., & Mattison, J. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180487 · Cited by 13
Gulino, R., Nunziata, D., de Leo, G., Kostenko, A., Emmi, S. A., & Leanza, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065613 · Cited by 8
Fructuoso, M., Vermeiren, Y., Boluda, S., Stimmer, L., Crans, R. A. J., Xicota, L., Eisel, U., Ortí-Casañ, N., Bun, P., Duyckaerts, C. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70262 · Cited by 14
Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease
Ohm, D. T., Fought, A. J., RADEMAKER, A. W., Kım, G., Sridhar, J., Coventry, C., Gefen, T. D., Weıntraub, S., Bigio, E. H., Mesulam, M. M., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12783 · Cited by 14
Self-citationLoss of mitochondrial enzyme GPT2 causes early neurodegeneration in locus coeruleus
Baytaş, O., Kauer, J. A., & Morrow, E. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105831 · Cited by 11
Li, M., Liu, S., Zhu, H., Guo, Z., Zhi, Y., Liu, R., Jiang, Z., Liang, X., Hu, H., & Zhu, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1014485 · Cited by 11
de Oliveira, R. B., Petiz, L. L., Lim, R., Lipski, J., Gravina, F. S., Brichta, A. M., Callister, R. J., Leão, R. N., & Helden, D. F. V. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14692 · Cited by 12
Behl, T., Kaur, I., Sehgal, A., Singh, S., Makeen, H. A., Albratty, M., Alhazmi, H. A., Bhatia, S., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113179 · Cited by 12
Emmerson, J. T., Malcolm, J. C., Carmo, S. D., Nguyen, P., Breuillaud, L., Martínez-Trujillo, J., & Cuello, A. C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106317 · Cited by 11
Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer’s disease
Ponnusamy, R., McNerney, M. W., Moghadam, S., & Salehi, A. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.035 · Cited by 11
Lechín, F., & van der Dijs, B. (2008) · The Open Neuroscience Journal · doi:10.2174/1874082000802010041 · Cited by 9
Wu, J., Toporek, A., Lin, Q., Goldstein, F. C., Loring, D. W., Kelberman, M. A., Weinshenker, D., Levey, A. I., Lah, J. J., & Qiu, D. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01701-1 · Cited by 10
Use of Light Therapy for Insomnia in the Elderly: Role of Circadian Rhythm Disorders
Cahan, J. G., & Abbott, S. M. (2020) · Current Sleep Medicine Reports · doi:10.1007/s40675-020-00181-z · Cited by 11
BAG2 prevents Tau hyperphosphorylation and increases p62/SQSTM1 in cell models of neurodegeneration
Lima, R. S., Carrettiero, D. C., & Ferrari, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07577-w · Cited by 10
Zeeman, M., Figeys, M., Brimmo, T., Burnstad, C., Hao, J., & Kim, E. (2023) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175231160010 · Cited by 10
AUTONOMIC NERVOUS SYSTEM DISORDERS
Henderson, R. D., & Spies, J. (2014) · CRC Press eBooks · doi:10.1201/b16337-25 · Cited by 10
Lechín, F., & van der Dijs, B. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195326697.003.0005 · Cited by 10
Sex-Related Motor Deficits in the Tau-P301L Mouse Model
Camargo, L. C., Honold, D., Bauer, R., Shah, N. J., Langen, K., Willbold, D., Kutzsche, J., Willuweit, A., & Schemmert, S. (2021) · Biomedicines · doi:10.3390/biomedicines9091160 · Cited by 9
Aruoma, O. I., Jen, S. S. M., Watts, H. R., George, J., Gentleman, S. M., Anderson, P. J., & Jen, L. (2008) · Toxicology · doi:10.1016/j.tox.2008.11.007 · Cited by 9
The Aged Dog as a Natural Model of Alzheimer’s Disease Progression
Araujo, J. A., Baulk, J., & de Rivera, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53219-6_4 · Cited by 9
Locus coeruleus pathology is associated with cerebral microangiopathy at autopsy
Freeze, W. M., van Veluw, S. J., Jansen, W. J., Bennett, D. A., & Jacobs, H. I. L. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13096 · Cited by 8
The role of sex differences in depression in pathologically defined Alzheimer’s disease
Tremblay, C., Choudhury, P., Belden, C. M., Goldfarb, D., Lorenzini, I., Beach, T. G., & Serrano, G. E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1156764 · Cited by 9
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease
Matt, R. A., Martin, R. S., Evans, A. K., Gever, J. R., Vargas, G. A., Shamloo, M., & Ford, A. P. D. W. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_677 · Cited by 11
Neurobiological Mechanisms Involved in the Pathogenesis of Alzheimer’s Disease
Mir, F. A., & Rizvi, Z. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_13 · Cited by 8
Calbindin-D28K, parvalbumin, and calretinin in young and aged human locus coeruleus
Lamerand, S. R., Shahidehpour, R. K., Ayala, I. A. D. L., Gefen, T. D., Mesulam, M. M., Bigio, E. H., & Geula, C. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.006 · Cited by 8
Self-citationPathogenese und Prävention des M. Alzheimer
Braak, H., Feldengut, S., & Tredici, K. D. (2013) · Der Nervenarzt · doi:10.1007/s00115-012-3688-1 · Cited by 8
Kim, E.-J., Vatsavayai, S., & Seeley, W. W. (2016) · The Behavioral Neurology of Dementia · doi:10.1017/9781139924771.008 · Cited by 7
Lee, M. K., & Chen, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095004 · Cited by 6
Noradrenaline Regulation of Brain-Body Communication
Fernandes, G., Lam, R. M., Park, J. H., Drummond, G. T., & Sur, M. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-89525-8_2 · Cited by 8
Chodari, L., Derafshpour, L., Jafari, A., Ghasemi, M., & Mehranfard, N. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148250 · Cited by 7
Zhang, K., Zhu, Y. W., Fenik, P., Fleysh, D., Ly, C., THOMAS, S. A., & Veasey, S. C. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1929-23.2024 · Cited by 8
Early β adrenoceptor dependent time window for fear memory persistence in APPswe/PS1dE9 mice
Karunakaran, S. (2021) · Scientific Reports · doi:10.1038/s41598-020-79487-5 · Cited by 7
Late-Life Depression as a Risk Factor for Dementia
Halperin, I. J. Y., & Korczyn, A. D. (2007) · Future Neurology · doi:10.2217/14796708.2.2.201 · Cited by 7
Chemoattractants and receptors in Alzheimer s disease
Le, Y. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s81 · Cited by 7
Neurotoxin-Induced DNA Damage is Persistent in SH-SY5Y Cells and LC Neurons
Wang, Y., Musich, P. R., Cui, K., Zou, Y., & Zhu, M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9521-4 · Cited by 7
Metadata
- Authors
- Grudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M.
- Affiliations
- Northwestern University (US)
- University of Miami (US)
- Corresponding author
- Mesulam, M. Marsel
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 28
- Issue
- 3
- Pages
- 327-335
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2168697938
- Cited by
- 396
- References
- 45
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 19 · 2023: 31 · 2022: 19 · 2021: 40 · 2020: 30 · 2019: 16 · 2018: 15 · 2017: 28 · 2016: 18 · 2015: 22 · 2014: 18 · 2013: 20 · 2012: 20
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Miami
- Northwestern University
- National Institute on Aging (P30AG013854)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- locus coeruleus, neurofibrillary degeneration, Alzheimer's disease, mild cognitive impairment, aging, tau protein, neurofibrillary tangles, noradrenergic projections, AT8, thioflavine S, tyrosine hydroxylase, cognitive decline, dementia
- MeSH terms
- Acetylcholinesterase, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Cognition Disorders, Female, Humans, Immunohistochemistry, Locus Coeruleus, Male, Middle Aged, Postmortem Changes, Psychological Tests, Reference Values, Tyrosine 3-Monooxygenase, Neurofibrillary Tangles, tau Proteins, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review